Carbowemb 450 mg/45 ml Injection belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

Carbowemb 450 mg/45 ml Injection contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

Carbowemb 450 mg/45 ml Injection is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Carbowemb 450 mg/45 ml Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking Carbowemb 450 mg/45 ml Injection for as long as your doctor has prescribed. Do not stop the Carbowemb 450 mg/45 ml Injection midway. Talk to your doctor before taking Carbowemb 450 mg/45 ml Injection if you have severe allergic reactions to Carbowemb 450 mg/45 ml Injection or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Carbowemb 450 mg/45 ml Injection should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Carbowemb 450 mg/45 ml Injection if you are pregnant or breastfeeding because this Carbowemb 450 mg/45 ml Injection can cause harmful effects on the unborn baby. Both women and men using this Carbowemb 450 mg/45 ml Injection should use birth control to avoid pregnancy.

Carbowemb 450 mg/45 ml Injection contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.

Carbowemb 450 mg/45 ml Injection should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Carbowemb 450 mg/45 ml Injection. To treat your condition effectually, continue taking Carbowemb 450 mg/45 ml Injection for as long as your doctor has prescribed. Do not stop the Carbowemb 450 mg/45 ml Injection midway. Talk to your doctor before taking Carbowemb 450 mg/45 ml Injection if you have severe allergic reactions to Carbowemb 450 mg/45 ml Injection or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Carbowemb 450 mg/45 ml Injection should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Carbowemb 450 mg/45 ml Injection if you are pregnant or breastfeeding because this Carbowemb 450 mg/45 ml Injection can cause harmful effects on the unborn baby. Both women and men using this Carbowemb 450 mg/45 ml Injection should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Carbowemb 450 mg/45 ml Injection treatment and appropriate until recovery is achieved.